Product Information for the User
Venlafaxine RetardTeva-ratiopharm150 mg prolonged-release hard capsules
This medicine contains the active ingredient venlafaxine.
Venlafaxine is an antidepressant that belongs to a group of medicines called serotonin and noradrenaline reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. It is believed that people who are depressed and/or anxious have lower levels of serotonin and noradrenaline in the brain. The exact way in which antidepressants work is not fully understood, but they may help to increase the levels of serotonin and noradrenaline in the brain.
Venlafaxina Retard Teva-ratiopharm is a treatment for adults with depression. It is also a treatment for adults with the following anxiety disorders: generalized anxiety disorder, social anxiety disorder (fear or avoidance of social situations), panic disorder (panic attacks). Treating depressive and anxiety disorders properly is important to help you feel better. If left untreated, your condition may not go away or may worsen and become harder to treat.
Warnings and precautions
Consult your doctor before starting to take Venlafaxina RetardTeva-ratiopharm:
This medicine may cause restlessness or difficulty sitting or staying still during the first few weeks of treatment. You should consult your doctor if this happens.
Do not drink alcohol during treatment with venlafaxine, as it may cause extreme tiredness and loss of consciousness. Taking it with certain medicines and/or alcohol may worsen the symptoms of depression and other conditions, such as anxiety disorders.
If you are depressed and/or have an anxiety disorder, you may sometimes have thoughts of harming yourself or suicide. These thoughts may increase when you start taking antidepressants, because all these medicines take time to work, usually two weeks but sometimes longer. These thoughts may also occur when your dose is reduced or during the interruption of treatment with venlafaxina.
This is more likely to happen:
Immediately contact your doctor or go to the nearest hospital if you have thoughts of harming yourself or suicide at any time.
You may find it helpful to tell a close relative or friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You may also ask them to tell you if they think your depression or anxiety is getting worse, or if they are concerned about changes in your behaviour.
Dry mouth
Dry mouth has been reported in 10% of patients treated with venlafaxine. This may increase the risk of tooth decay. Therefore, you should take good care of your dental hygiene.
Diabetes
Your blood glucose levels may be affected by venlafaxine. Therefore, you may need to adjust your diabetes medicines.
Sexual problems
Some medicines in the group to which venlafaxine belongs (IRSNs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persist after stopping treatment.
Beads in chains
Do not worry if you see small white grains or beads in your stools after taking this medicine. Inside the capsules of Venlafaxina RetardTeva-ratiopharmthere are beads (small white grains) that contain the active ingredient (venlafaxine). These beads are released from the capsule in the stomach. As they travel through the stomach and intestines, venlafaxine is slowly released. The “skin” of the bead remains undissolved and is eliminated in the stools. Therefore, although you may see beads in your stools, your dose of medicine has been absorbed.
This medicine should not be used normally in the treatment ofchildren and adolescents under 18 years of age. Also, you should know that in patients under 18 yearsthere is agreater risk of side effects such as suicidal thoughts,suicidal ideationand hostility (predominantly aggression, confrontational behaviour and irritability) when they take this type of medicine. Although, the doctor who prescribes this medicine to you may prescribe it to patients under 18 years of age when they decide that it is the most convenient option for the patient. Ifthe doctor who prescribes this medicine to youhas prescribed it to a patient under 18 years of age and wants to discuss this decision,please, go back to your doctor. You should inform your doctor if any of the symptoms listed above develop or worsen in these patients under 18 years of age who are taking venlafaxine. Also, the long-term effectson safety and those related to growth, maturation and cognitive and behavioural developmentof this medicine in this age group have not yet been demonstrated.
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine.
Your doctor must decide if you can take venlafaxine with other medicines.
Do not start or stop taking any medicine, including those available over the counter, natural remedies and herbal remedies, before checking with your doctor or pharmacist.
A potentially fatal or reactions similar to Malignant Neuroleptic Syndrome (MNS) (see section “Possible side effects”), may occur with treatment with venlafaxine, particularly when taken with other medicines.
Examples of these medicines include:
The signs and symptoms of serotonin syndrome may include a combination of the following:
Restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, hyperactive reflexes, diarrhea, coma, nausea, vomiting.
In its most severe form, serotonin syndrome may resemble Malignant Neuroleptic Syndrome (MNS). The signs and symptoms of MNS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by blood test).
Inform your doctor immediately or go to the nearest hospital if you think you are experiencing serotonin syndrome.
Inform your doctor if you are taking medicines that may affect your heart rhythm.
Some examples of these medicines include:
The following medicines may also interact with venlafaxine and should be used with caution. It is especially important to mention to your doctor or pharmacist if you are taking medicines that contain:
Venlafaxine should be taken with food (see section 3 “How to take Venlafaxina Retard Teva-ratiopharm”).
Do not drink alcohol during treatment with venlafaxine. Taking it with alcohol may cause extreme tiredness and loss of consciousness, and worsen the symptoms of depression and other conditions, such as anxiety disorders.
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medicine. You should only take venlafaxine after discussing the possible benefits and risks for the unborn baby with your doctor.
Make sure your midwife and/or doctor knows that you are taking venlafaxine. When taken during pregnancy, similar medicines (SSRIs) may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and appear blue. These symptoms usually start within the first 24 hours after the baby's birth. If this happens to your baby, contact your midwife and/or doctor immediately.
If you take this medicine in the final stages of pregnancy, there may be a greater risk of heavy vaginal bleeding after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking venlafaxine so they can advise you.
If you are taking this medicine during pregnancy,in addition to breathing problems, other symptoms that your baby may have when born is feeding problems. If your baby has these symptoms when born and you are concerned, contact your doctor and/or midwife who can advise you.
Venlafaxine passes into breast milk. There is a risk of an effect on the baby. Therefore, you should discuss the case with your doctor and they will decide whether you should stop breastfeeding or stop taking this medicine.
Do not drive or operate tools or machines until you know how this medicine affects you.
Venlafaxina RetardTeva-ratiopharmcontains saccharose
If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
The usual recommended initial dose for the treatment of depression, generalized anxiety disorder, and social anxiety disorder is 75 mg per day. Your doctor may gradually increase the dose and if necessary, even more up to a maximum of 375 mg per day for depression. If you are being treated for panic disorder, your doctor will start with a lower dose (37.5 mg) and then gradually increase the dose. The maximum dose for generalized anxiety disorder, social anxiety disorder, and panic disorder is 225 mg/day.
Venlafaxine RetardTeva-ratiopharmis for oral use.
Take this medication approximately at the same time every day, either in the morning or at night. To ensure the complete swallowing of the granules (spheres within the capsules), the capsules must be swallowed whole with liquids and should not be opened, crushed, chewed, or dissolved.
This medication should be taken with food.
If you have liver or kidney problems, talk to your doctor as your dose of this medication may need to be different.
Do not stop taking this medication without consulting your doctor (see section “If you interrupt treatment with Venlafaxine Retard Teva-ratiopharm”).
If you take more of this medication than prescribed by your doctor or in case of accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount taken.
Overdose can put your life in danger, especially with the simultaneous taking of certain medications and/or alcohol (see “Taking Venlafaxine RetardTeva-ratiopharmwith other medications”).
The symptoms of a possible overdose may include palpitations, changes in alertness level (ranging from drowsiness to coma), blurred vision, seizures or attacks, and vomiting.
If you have not taken a dose, take it as soon as you remember. However, if it is already time for your next dose, skip the missed dose and take only one dose as usual. Do not take a double dose to compensate for the missed doses. Do not take more than the daily dose of this medication that your doctor has prescribed for you in a day.
Do not stop taking your treatment or reduce the dose without consulting your doctor, even if you feel better. If your doctor thinks you no longer need this medication, they may ask you to gradually reduce the dose before stopping treatment completely. It is known that adverse effects occur when people stop using this medication, especially when it is stopped suddenly or if the dose is reduced very quickly. Some patients may experience symptoms such as suicidal thoughts, aggression, fatigue, dizziness, lack of stability, headaches, insomnia, nightmares, dry mouth, loss of appetite, nausea, diarrhea, nervousness, agitation, confusion, ringing in the ears, tingling or, in rare cases, electric shock sensations, weakness, sweating, seizures, or symptoms similar to the flu, vision problems, and increased blood pressure (which can cause headaches, dizziness, ringing in the ears, sweating, etc.).
Your doctor will advise you on how to gradually stop treatment with this medication. This may take several weeks or months. In some patients, the interruption may need to be very gradual over months or more. If you experience any of these or other symptoms that bother you, consult your doctor for further advice.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If any of the following effects occur, do not take this medicine.Inform your doctor immediately, or go to the nearest hospital emergency department:
Rare (may affect up to 1 in 100 people)
Uncommon (may affect up to 1 in 1,000 people)
In its most severe form, serotonin syndrome can resemble Neuroleptic Malignant Syndrome (NMS). The symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle rigidity, confusion, and increased muscle enzymes (determined by blood tests)
Unknown frequency (cannot be estimated from available data)
Other side effects that may occur
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 100 people)
Very rare (may affect up to 1 in 10,000 people)
Unknown frequency (cannot be estimated from available data)
This medicine may sometimes cause unwanted effects that you may not be aware of, such as increased blood pressure or abnormal heartbeats; mild changes in liver enzyme levels, sodium, or cholesterol levels. Less frequently, venlafaxine may reduce the function of blood platelets, leading to an increased risk of thrombocytopenia or bleeding. Therefore, your doctor may wish to perform occasional blood tests, particularly if you have been taking venlafaxine for a long time.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use Website:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not usethis medication after the expiration date that appears on the packaging and blister pack after CAD. The expiration date is the last day of the month indicated.
Store below 30°C.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and unused medicines at the SIGRE point of the pharmacy.In case of doubt, ask your pharmacist how to dispose of the packaging and unused medicines. By doing so, you will help protect the environment.
The active ingredient is venlafaxine.
Each extended-release capsule contains venlafaxine hydrochloride, equivalent to 150mg of venlafaxine.
The other components are:
Capule content:Sugar spheres (sucrose and maize starch), hypromellose, ethylcellulose, talc.
Capule coating:Yellow iron oxide (E172), titanium dioxide (E171), gelatin, red iron oxide (E172).
Printing ink:Lacquers, propylene glycol (E1520), strong ammonia solution (E527), black iron oxide (E172), potassium hydroxide.
Hard gelatin capsules, with a brown opaque cap and body, filled with white to beige microgranules. The capsules are printed with black ink with “VNL” on the cap and the number “150” on the body. The capsule is approximately 24 mm x 8 mm.
Blister packs of 10, 14, 20, 28, 30, 50, 98, 100 extended-release hard capsules or perforated single-dose blister packs of 100x1 extended-release hard capsules.
HDPE bottles with PP screw cap: pack sizes of 30, 150 extended-release hard capsules.
Only some pack sizes may be marketed.
Teva B.V.
Swensweg 5,
2031GA Haarlem
Netherlands
Teva Pharma S.L.U.
C/C, n. 4, Industrial Estate Malpica
50016 Zaragoza, Spain
For further information about this medicinal product, please contact the local representative of the marketing authorization holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11, Edificio Albatros B, 1st floor
28108 Alcobendas, Madrid (Spain)
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Germany:Venlafaxin-AbZ 150 mg Hartkapseln, retardiert
Spain:Venlafaxina Retard Teva-ratiopharm 150 mg extended-release capsules
Portugal:Venlafaxina Teva
Last review date of this leaflet:May 2023
Further detailed information on this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
You can access detailed and updated information about this medicinal product by scanning with your mobile phone (smartphone) the QR code included in the carton or by accessing the following internet address:https://cima.aemps.es/cima/dochtml/p/87921/P_87921.html
QR code+ URL
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.